May 7 (Reuters) - CSPC Pharmaceutical Group Ltd :
* INVESTIGATIONAL FIRST-IN-CLASS PRODUCT SYSA1801 GRANTED ORPHAN-DRUG DESIGNATION BY U.S. FDA
Source text for Eikon: Further company coverage:
May 7 (Reuters) - CSPC Pharmaceutical Group Ltd :
* INVESTIGATIONAL FIRST-IN-CLASS PRODUCT SYSA1801 GRANTED ORPHAN-DRUG DESIGNATION BY U.S. FDA
Source text for Eikon: Further company coverage:
精彩评论